Different patterns of stromal and cancer cell thymidine phosphorylase reactivity in non-small-cell lung cancer: impact on tumour neoangiogenesis and survival
1998

Thymidine Phosphorylase in Non-Small-Cell Lung Cancer

Sample size: 141 publication Evidence: moderate

Author Information

Author(s): Ml Koukourakis, A Giatromanolaki, S Kakolyris, KJ O'Byrne, N Apostolikas, J Skarlatos, KC Gatter, AL Harris

Primary Institution: University Hospital of Iraklion, Greece; Oxford Radcliffe Hospital, UK; Hellenic Cancer Institute, Greece

Hypothesis

What is the role of thymidine phosphorylase in the angiogenesis and survival of non-small-cell lung cancer?

Conclusion

Stromal macrophage and fibroblast thymidine phosphorylase reactivity may significantly influence the behavior of non-small-cell lung cancer.

Supporting Evidence

  • Cancer cell thymidine phosphorylase overexpression was related to high vascular grade and poor prognosis.
  • Fibroblast thymidine phosphorylase overexpression correlated with high angiogenesis.
  • Intense macrophage infiltration was associated with fibroblast thymidine phosphorylase reactivity.

Takeaway

This study found that certain cells in lung cancer can help tumors grow new blood vessels, which can affect how well patients do.

Methodology

The study analyzed 141 early stage non-small-cell lung cancer cases using immunohistochemical techniques to assess thymidine phosphorylase reactivity and vascular grade.

Limitations

The study only included patients who underwent surgery and survived at least 60 days, which may limit the generalizability of the findings.

Participant Demographics

The study included 141 patients with early stage I-II non-small-cell lung cancer, with a median follow-up of 30 months.

Statistical Information

P-Value

0.0004

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication